Dublin, Ireland, June 18, 2007. ICON plc (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries today announced that it has set up a dedicated business group within its Clinical Research division focused on observational research and analysis services.
